Delisting risk
MetaVia (MTVA)
Clinical developer of obesity and MASH therapies.
$1.83
Pre-market−0.01 (−0.56%)
At close$1.84(+6.98%)
Something off on this page? Send us feedback.
Next report
Nov 5, 2026
estimated · in 63 days
EPS estimate
−$0.73
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$1.76−$0.36−$0.26−$1.54$1.01−$0.79−$0.90Pending
Estimate−$0.72−$0.57−$0.32−$2.86−$2.06−$0.76−$0.82−$0.73
Surprise−144.4%+36.8%+18.8%+46.2%+149.0%−3.9%−9.8%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.73 | — | — |
| Aug 2026 | −$0.82 | −$0.90 | −9.8% |
| May 2026 | −$0.76 | −$0.79 | −3.9% |
| Mar 2026 | −$2.06 | $1.01 | +149.0% |
| Nov 2025 | −$2.86 | −$1.54 | +46.2% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Dec 2024 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Mar 2024 | |||
| Dec 2023 | |||
| Nov 2023 | |||
| Sep 2023 | |||
| Jun 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$0.73 | — | — | — | — | — | — |
| Aug 6, 2026 | −$0.82 | −$0.90 | −9.8% | — | — | — | +2.8% |
| May 14, 2026 | −$0.76 | −$0.79 | −3.9% | — | — | — | −6.7% |
| Mar 26, 2026 | −$2.06 | $1.01 | +149.0% | — | — | — | −7.6% |
| Nov 6, 2025 | −$2.86 | −$1.54 | +46.2% | — | — | — | +6.8% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 7, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 27, 2025 | |||||||
| Dec 31, 2024 | |||||||
| Nov 7, 2024 | |||||||
| Aug 14, 2024 | |||||||
| Mar 31, 2024 | |||||||
| Dec 31, 2023 | |||||||
| Nov 13, 2023 | |||||||
| Sep 30, 2023 | |||||||
| Jun 30, 2023 | |||||||
| May 12, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Dec 31, 2022 | |||||||
| Sep 30, 2022 | |||||||
| Jun 30, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Dec 31, 2021 | |||||||
| Sep 30, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 | |||||||